BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34362529)

  • 1. [Research Status of TPO/c-MPL Signaling Pathway in Acute Myeloid Leukemia--Review].
    Wang N; Zhu HY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Aug; 29(4):1351-1354. PubMed ID: 34362529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombopoietin: expression of its receptor MPL and proliferative effects on leukemic cells.
    Drexler HG; Quentmeier H
    Leukemia; 1996 Sep; 10(9):1405-21. PubMed ID: 8751457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemia cells.
    Quentmeier H; Zaborski M; Graf G; Ludwig WD; Drexler HG
    Leukemia; 1996 Feb; 10(2):297-310. PubMed ID: 8637239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of thrombopoietin on the growth of acute myeloblastic leukemia cells.
    Matsumura I; Ikeda H; Kanakura Y
    Leuk Lymphoma; 1996 Nov; 23(5-6):533-8. PubMed ID: 9031083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating thrombopoietin as an in vivo growth factor for blast cells in acute myeloid leukemia.
    Corazza F; Hermans C; D'Hondt S; Ferster A; Kentos A; Benoît Y; Sariban E
    Blood; 2006 Mar; 107(6):2525-30. PubMed ID: 16317100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of human leukemia-lymphoma cell lines in hematological research: effects of thrombopoietin on human leukemia cell lines.
    Drexler HG; Quentmeier H
    Hum Cell; 1996 Dec; 9(4):309-16. PubMed ID: 9183663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study of thrombopoietin and its receptor C-mpl in acute leukemia].
    Guo Y; Bian S; Luo M
    Zhonghua Xue Ye Xue Za Zhi; 1999 Mar; 20(3):120-3. PubMed ID: 11601235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coexpression of thrombopoietin and c-mpl genes in human acute myeloblastic leukemia cells.
    Matsumura I; Kanakura Y; Ikeda H; Ishikawa J; Yoshida H; Horikawa Y; Nishiura T; Tahara T; Kato T; Miyazaki H; Matsuzawa Y
    Leukemia; 1996 Jan; 10(1):91-4. PubMed ID: 8558944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The TPO/c-MPL pathway in the bone marrow may protect leukemia cells from chemotherapy in AML Patients.
    Dong-Feng Z; Ting L; Yong Z; Cheng C; Xi Z; Pei-Yan K
    Pathol Oncol Res; 2014 Apr; 20(2):309-17. PubMed ID: 24085601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombopoietin-based CAR-T cells demonstrate in vitro and in vivo cytotoxicity to MPL positive acute myelogenous leukemia and hematopoietic stem cells.
    Zoine JT; Prince C; Story JY; Branella GM; Lytle AM; Fedanov A; Alexander JS; Porter CC; Doering CB; Spencer HT; Chandrakasan S
    Gene Ther; 2022 May; 29(5):1-12. PubMed ID: 34385604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth response of acute myeloblastic leukemia cells to recombinant human thrombopoietin.
    Matsumura I; Kanakura Y; Kato T; Ikeda H; Ishikawa J; Horikawa Y; Hashimoto K; Moriyama Y; Tsujimura T; Nishiura T
    Blood; 1995 Jul; 86(2):703-9. PubMed ID: 7541672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of thrombopoietin receptor and its functional role in human B-precursor leukemia cells with 11q23 translocation or Philadelphia chromosome.
    Iijima K; Sugita K; Inukai T; Goi K; Tezuka T; Uno K; Sato H; Kagami K; Nakazawa S
    Leukemia; 2000 Sep; 14(9):1598-605. PubMed ID: 10995006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the MPL receptor in myeloproliferative disorders.
    Kaushansky K
    Leukemia; 1998 Sep; 12 Suppl 1():S47-50. PubMed ID: 9777896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mpl: from an acute myeloproliferative virus to the isolation of the long sought thrombopoietin.
    Souyri M
    Semin Hematol; 1998 Jul; 35(3):222-31. PubMed ID: 9685168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombopoietin stimulates colony-forming unit-megakaryocyte proliferation and megakaryocyte maturation independently of cytokines that signal through the gp130 receptor subunit.
    Broudy VC; Lin NL; Fox N; Taga T; Saito M; Kaushansky K
    Blood; 1996 Sep; 88(6):2026-32. PubMed ID: 8822921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of thrombopoietin and its receptor (c-mpl) in chronic myelogenous leukemia: correlation with disease progression and response to therapy.
    Kaban K; Kantarjian H; Talpaz M; O'Brien S; Cortes J; Giles FJ; Pierce S; Albitar M
    Cancer; 2000 Feb; 88(3):570-6. PubMed ID: 10649249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lnk inhibits Tpo-mpl signaling and Tpo-mediated megakaryocytopoiesis.
    Tong W; Lodish HF
    J Exp Med; 2004 Sep; 200(5):569-80. PubMed ID: 15337790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The biologic properties of recombinant human thrombopoietin in the proliferation and megakaryocytic differentiation of acute myeloblastic leukemia cells.
    Matsumura I; Kanakura Y; Kato T; Ikeda H; Horikawa Y; Ishikawa J; Kitayama H; Nishiura T; Tomiyama Y; Miyazaki H; Matsuzawa Y
    Blood; 1996 Oct; 88(8):3074-82. PubMed ID: 8874206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of thrombopoietin on proliferation of blasts from CD7-positive acute myelogenous leukaemia.
    Tokunaga Y; Miyamoto T; Okamura T; Eto T; Gondo H; Kamimura T; Okamura S; Niho Y
    Br J Haematol; 1998 Sep; 102(5):1232-40. PubMed ID: 9753051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombopoietin and the c-Mpl receptor: insights from gene targeting.
    Alexander WS
    Int J Biochem Cell Biol; 1999 Oct; 31(10):1027-35. PubMed ID: 10582337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.